PHARMENABLE
PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery of vital new medicines.
PHARMENABLE
Industry:
Biotechnology Life Science Medical Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pharmenable.com
Total Employee:
1+
Status:
Active
Total Funding:
4.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Current Employees Featured
Founder
Investors List
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Seed Round - PharmEnable
Parkwalk Advisors
Parkwalk Advisors investment in Seed Round - PharmEnable
Pitch@Palace
Pitch@Palace investment in Non Equity Assistance - PharmEnable
Newest Events participated
Official Site Inspections
http://www.pharmenable.com Semrush global rank: 3.69 M Semrush visits lastest month: 3.78 K
- Host name: 217.1.214.35.bc.googleusercontent.com
- IP address: 35.214.1.217
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "PharmEnable"
Accessing the Inaccessible - PharmEnable Therapeutics
Read up on the latest news, updates and announcements from the PharmEnable team. See All News. Clinical oncology pioneer joins PharmEnable’s board. Read More. PharmEnable …See details»
Our Story - PharmEnable Therapeutics
At PharmEnable Hannah has put together an exceptional team of world-class scientists and entrepreneurs driven by a shared mission: to create revolutionary new medicines. A passion for chemical diversity. Natalia’s story. Our COO Dr …See details»
PharmEnable - Crunchbase Company Profile & Funding
Organization. PharmEnable . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
PharmEnable Therapeutics - LinkedIn
PharmEnable Therapeutics | 2,592 followers on LinkedIn. Harnessing the power of chemical novelty, diversity and 3-dimensionality to develop innovative small molecule drugs | PharmEnable is a ...See details»
PharmEnable Team - PharmEnable Therapeutics
At PharmEnable Therapeutics we are leading the charge by Accessing the Inaccessible. Hannah brings over 25 years of research expertise within the life sciences and drug discovery sector at Millennium Pharmaceuticals, Astex …See details»
PharmEnable Information - RocketReach
PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies. With our proprietary AI …See details»
PharmEnable - Contacts, Employees, Board Members, Advisors
Organization. PharmEnable . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. PharmEnable has 4 current …See details»
PharmEnable Company Profile - Office Locations, Competitors
PharmEnable is a biotech company supporting early drug discovery programs by providing a platform to identify new candidates. It uses its virtual compound library in conjunction with its …See details»
PharmEnable Therapeutics Ltd. - Drug pipelines, Patents, Clinical ...
Explore PharmEnable Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 4 news, Disease Domain:Nervous System Diseases, Neoplasms, Technology …See details»
PharmEnable - Org Chart, Teams, Culture & Jobs | The Org
View PharmEnable's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
PharmEnable's Leadership Team - Team members and org chart
The leadership team at PharmEnable has a wealth of experience in the healthcare and scientific research industries, as well as in business mentoring and accelerators. They have also been …See details»
PharmEnable Therapeutics Ltd. (PharmEnable Therapeutics Ltd.)
The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled platform for designing high quality …See details»
PharmEnable - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Non Equity Assistance - …See details»
PharmEnable | Collaboration and Impact - Yusuf Hamied …
PharmEnable. PharmEnable was co-founded in 2016 by then Spring Group Research Manager Dr Hannah Sore and postdoctoral researcher Dr Natalia Mateu, Professor David Spring, Dr …See details»
Pipeline - PharmEnable Therapeutics
At PharmEnable Therapeutics our mission is to develop innovative treatments for diseases with high unmet clinical need. With our scientist led, AI-enhanced approach, our aim is to create a …See details»
Pharmenable | VentureRadar
At PharmEnable we support early drug discovery programs by providing a rapid, cost efficient, and effective platform to identify new hit candidates. At PharmEnable we use our unique and …See details»
PharmEnable Closes $7.5M Financing led by MP Healthcare to
May 22, 2023 Dr Jelena Aleksic, CBO, PharmEnable, [email protected] Media enquiries Gemma Moses, Communications Consultant, [email protected], …See details»
PharmEnable raises $7.5M to develop small molecule drugs
May 25, 2023 PharmEnable, a drug discovery company focused on chemical novelty, diversity and complexity, announces it has closed a Pre-Series A investment round of $7.5M to develop the next generation of small molecule drugs against disease areas of high clinical need.. The funding round was led by MP Healthcare Venture Management (MPH), the venture arm of Mitsubishi …See details»
PharmEnable Closes $7.5M Financing led by MP Healthcare
PharmEnable has a pipeline of wholly owned oncology programmes, as well as ongoing co-discovery projects with several pharma and biotech companies, including a partnership with Sosei Heptares to unlock novel drug candidates for neurological disease. The wholly owned programmes focus on addressing some of the key challenges in oncology such as ...See details»
PharmEnable: Creating new medicines with an AI-enabled platform
Dec 10, 2024 PharmEnable has made significant strides in drug discovery. One of their notable achievements is the development of small molecule drugs that mimic the specificity of …See details»